Patterns of αvβ3 expression in primary and metastatic human breast cancer as shown by 18F-galacto-RGD PET

被引:153
作者
Beer, Ambros J. [1 ]
Niemeyer, Markus [2 ]
Carlsen, Janette [1 ]
Sarbia, Mario [3 ]
Naehrig, Joerg [3 ]
Watzlowik, Petra [1 ]
Wester, Hans-Juergen [1 ]
Harbeck, Nadia [2 ]
Schwaiger, Markus [1 ]
机构
[1] Tech Univ Munich, Dept Nucl Med, Klinikum Rechts Isar, D-81675 Munich, Germany
[2] Tech Univ Munich, Dept Gynecol, Klinikum Rechts Isar, D-81675 Munich, Germany
[3] Tech Univ Munich, Dept Pathol, Klinikum Rechts Isar, D-81675 Munich, Germany
关键词
breast cancer; integrins; alpha(v) beta(3); angiogenesis; PET; RGD; POSITRON-EMISSION-TOMOGRAPHY; VASCULAR INTEGRIN ALPHA(V)BETA(3); ANGIOGENESIS; MIGRATION;
D O I
10.2967/jnumed.107.045526
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The integrin alpha(v)beta(3) is a key player in angiogenesis and metastasis. Our aim was to study the uptake patterns of the alpha(v)beta(3)-selective PET tracer F-18-galacto-RGD in invasive ductal breast cancer. Methods: Sixteen patients with primary (n = 12) or metastasized breast cancer (n = 4) were examined with F-18-galacto-RGD PET. Standardized uptake values (SUVs) were derived by region-of-interest analysis, and immunohistochemistry of (x (33 expression was performed (n = 5). Results:F-18-Galacto-RGD PET identified all invasive carcinomas, with SUVs from 1.4 to 8.7 (mean +/- SD, 3.6 +/- 1.8; tumor-to-blood and tumor-to-muscle ratios, 2.7 +/- 1.6 and 6.2 +/- 2.2, respectively). Lymph-node metastases were detected in 3 of 8 patients (mean SUV, 3.3 +/- 0.8). SUVs in distant metastases were heterogeneous (2.9 +/- 1.4). Immunohistochemistry confirmed a (33 expression predominantly on microvessels (5/5) and, to a lesser extent, on tumor cells (3/5). Conclusion: Our results suggest generally elevated and highly variable a alpha(v)beta(3) expression in human breast cancer lesions. Consequently, further imaging studies with F-18-galacto-RGD PET in breast cancer patients for assessment of angiogenesis or planning of alpha(v)beta(3)-targeted therapies are promising.
引用
收藏
页码:255 / 259
页数:5
相关论文
共 20 条
  • [1] Bach-Gansmo T, 2006, J NUCL MED, V47, P1434
  • [2] Beer AJ, 2006, J NUCL MED, V47, P763
  • [3] Beer AJ, 2005, J NUCL MED, V46, P1333
  • [4] Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin αvβ3 expression in man
    Beer, Ambros J.
    Haubner, Roland
    Sarbia, Mario
    Goebel, Michael
    Luderschmidt, Stephan
    Grosu, Anca Ligia
    Schnell, Oliver
    Niemeyer, Markus
    Kessler, Horst
    Wester, Hans-Juergen
    Weber, Wolfgang A.
    Schwaiger, Markus
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (13) : 3942 - 3949
  • [5] Integrin expression and survival in human breast cancer
    Berry, MG
    Gui, GPH
    Wells, CA
    Carpenter, R
    [J]. EJSO, 2004, 30 (05): : 484 - 489
  • [6] Brix G, 2002, NUKLEARMED-NUCL MED, V41, P184
  • [7] REQUIREMENT OF VASCULAR INTEGRIN ALPHA(V)BETA(3) FOR ANGIOGENESIS
    BROOKS, PC
    CLARK, RAF
    CHERESH, DA
    [J]. SCIENCE, 1994, 264 (5158) : 569 - 571
  • [8] ANTIINTEGRIN ALPHA-V-BETA-3 BLOCKS HUMAN BREAST-CANCER GROWTH AND ANGIOGENESIS IN HUMAN SKIN
    BROOKS, PC
    STROMBLAD, S
    KLEMKE, R
    VISSCHER, D
    SARKAR, FH
    CHERESH, DA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (04) : 1815 - 1822
  • [9] Burke PA, 2002, CANCER RES, V62, P4263
  • [10] Damjanovich L, 1997, Acta Chir Hung, V36, P69